Palo Capital’s Repligen RGEN Stock Holding History

Palo Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,786	Closed	-$209K	–	237
2016 Q1	$209K	Buy	+7,786	New	+$191K	0.16%	127

Other funds holding RGEN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Palo Capital's RGEN Position: Q2 2016 in Review

Palo Capital sold out of Repligen (RGEN) in Q2 2016, closing a stake of 7,786 shares — an estimated $209K sold.

Palo Capital first reported a position in RGEN in Q1 2016 and held it in 1 quarter. The position peaked at $209K in Q1 2016. 186 funds tracked by Wall St. Rank hold RGEN as of Q2 2016.

Palo Capital reported no remaining Repligen position as of Q2 2016 after selling out during the quarter.
Palo Capital sold 7,786 Repligen shares in Q2 2016, an estimated $209K.
Palo Capital first reported a position in Repligen in Q1 2016 and held it in 1 quarter.
Palo Capital's Repligen position peaked at $209K in Q1 2016.
186 funds tracked by Wall St. Rank held Repligen as of Q2 2016.

Based on Palo Capital's 13F filing for Q2 2016, filed 20 Jul 2016.